Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer - Quiz - MDSpire

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer

  • By

  • Soraia Lobo-Martins

  • Diogo Martins-Branco

  • Francine Padonou

  • Hafid Dahma

  • Sigi van den Wijngaert

  • Mounia Jaouart

  • Chiara Dauccia

  • Chiara Molinelli

  • Elisa Agostinetto

  • Angela Loizidou

  • Donatienne Taylor

  • Anais Boisson

  • Soizic Garaud

  • Chloé Spilleboudt

  • Jose Vicente Cardona

  • Peter Ramge

  • Bogdana Ioana Balas

  • Mohammed Bajji

  • Fanny George

  • Tabatha Delsaute

  • Marianne Paesmans

  • Lieveke Ameye

  • Martine Piccart

  • Evandro de Azambuja

  • Karen Willard-Gallo

  • May 20, 2026

  • 0 min

Share

Original Source(s)

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer

  • by Soraia Lobo-Martins, Diogo Martins-Branco, Francine Padonou, Hafid Dahma, Sigi van den Wijngaert, Mounia Jaouart, Chiara Dauccia, Chiara Molinelli, Elisa Agostinetto, Angela Loizidou, Donatienne Taylor, Anais Boisson, Soizic Garaud, Chloé Spilleboudt, Jose Vicente Cardona, Peter Ramge, Bogdana Ioana Balas, Mohammed Bajji, Fanny George, Tabatha Delsaute, Marianne Paesmans, Lieveke Ameye, Martine Piccart, Evandro de Azambuja, Karen Willard-Gallo

  • May 20, 2026

Related Content

Potential targets for boron transport in boron neutron capture therapy

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort